QA: Carisma Therapeutics Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001485003_2022_Carisma_Therapeutics_Inc.pdf

Logs

warning The stock_price does not exist industry.us_generic {}

Graph

Absolute values for 0001485003, Carisma Therapeutics Inc

  xvar xval
0 AssetsCurrent 205,605,000
1 IntangibleAssetsNetIncludingGoodwill 27,764,000
2 PropertyPlantAndEquipmentNet 43,000
3 remainder_Assets 7,335,000
4 LiabilitiesCurrent 11,568,000
5 LiabilitiesNoncurrent 57,469,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 29,120,399
9 ResearchAndDevelopmentExpense 25,098,930
10 remainder_Expenses -23,220,366
11 remainder_Revenues 102,970,099
12 remainder_NetIncome -2,666
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 240,747,000
1 Liabilities 69,037,000
2 Expenses 30,998,963
3 Revenues 102,970,099
4 StockholdersEquity 171,710,000
5 NetIncome 71,968,470
6 ComprehensiveNetIncome 71,968,470
7 BaseVar 221,877,864
8 EconomicCapitalRatiobeforeLimitedLiability 2.88
9 EconomicCapitalRatio 3.61

Edgar->Model Mapping

Feature Distribution

Change over Time